FDA approves Pluvicto for Prostate Cancer

Novartis is a global medicine company using innovative science and digital technologies to create transformative treatments in areas of great medical need, including late-stage prostate cancer.  Today it was announced the Company had received FDA Approval for Pluvicto™, the first targeted radiopharmaceutical therapy (RPT) for treatment of progressive prostate cancer. Pluvicto (Lutetium-177 vipivotide tetraxetan, commonly […]

Strategic Investment in Medical Data Sharing & Standards

Clinical adoption of Personalized Treatment Planning for Radiopharmaceutical Therapy (RPT) depends upon seamless department workflows. Clinical images must be imported to the planning system, and the results of a plan assessment or an approved treatment plan must be exported to hospital data centers. This work is accomplished via complex data standards that continue to evolve. […]

Voximetry awarded second advance matching grant from WEDC

Voximetry, Inc. has been awarded a second SBIR Advance Matching grant sponsored by the Center for Technology Commercialization (CTC), part of the Wisconsin Economic Development Corporation (WEDC). This $100,000 award includes state match funding of Voximetry’s NIH SBIR Phase II grant, leadership training, and other resources to advance the commercialization of Small Business Innovation Research […]

Voximetry strengthens image processing capabilities

Voximetry announces another strategic product development investment with the hiring of Dr. Chuck Stearns. Dr. Stearns has over 30 years of experience in PET/CT scanner design, data processing and image reconstruction. “Chuck’s deep domain knowledge in nuclear medicine imaging technology will solidify Voximetry’s ability to focus on image data inputs to Torch™, our advanced dosimetry […]

Voximetry awarded $397,000 NIH Phase I contract

MADISON, Wis.–Voximetry Incorporated has been awarded nearly $400,000 from the U.S. National Cancer Institute, National Institutes of Health, Department of Health and Human Services to improve the quantitative accuracy of nuclear medicine SPECT/CT images used in the planning and assessment of Radiopharmaceutical Therapy (RPT). This is the third significant grant or contract awarded to the […]

Voximetry awarded $100,000 SBIR advance match grant

Voximetry, Inc. has been accepted into the spring 2021 SBIR Advance program sponsored by the Center for Technology Commercialization (CTC), part of the Wisconsin Economic Development Corporation (WEDC). The program provides state match funding, training, and other resources to Wisconsin businesses to advance the commercialization of Small Business Innovation Research (SBIR) funded technology and expedite […]

Voximetry names Sue Wallace as CEO

Voximetry continues its momentum with hiring of Chief Executive Officer Dr. Sue Wallace. MADISON, Wis.– Voximetry Inc., a Madison, Wisconsin-based Healthtech software company with unique technology for personalized Radiopharmaceutical Therapy (RPT) planning, has announced the permanent appointment of Susan L. Wallace, PhD as Chief Executive Officer. Voximetry’s Torch™ software platform implements proprietary Monte Carlo algorithms […]

IROC to use Torch™ in upcoming NCTN clinical trials

Imaging and Radiation Oncology Core (IROC) to Evaluate α- and β- Dosimetry with Torch™ According to the scientific needs of clinical trials led by the National Clinical Trials Network (NCTN), groups receive support from the IROC group and others. To support current and future trials, IROC plans to evaluate the potential of dosimetry in alpha- […]

Strategic product development investment

Voximetry makes a strategic product development investment with the hiring of Sankara Hari Gopalakrishnan. Mr. Gopalakrishnan brings with him a wealth of radiation oncology domain knowledge and experience in Healthtech product development. With over ten years experience as a research scientist and product developer, he is a recognized expert in optimization of radiation therapy to […]

Voximetry receives $1.8M SBIR phase II grant

Voximetry Awarded $1.8 Million Grant from National Cancer Institute to Advance the Development of its Radiopharmaceutical Therapy Dosimetry Software MADISON, Wis.–Voximetry Inc., an early stage medical software company with unique technology for personalized Radiopharmaceutical Therapy (RPT) planning, has been awarded a substantial grant from the U.S. National Institutes of Health (NIH)’s National Cancer Institute (NCI) […]